FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder-Reference-Cited by-同舟云学术

FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder

Published:2014-05-21 Issue:4 Volume:3 Page:835-844
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Guancial Elizabeth A.¹²,Werner Lillian³,Bellmunt Joaquim¹⁴,Bamias Aristotle⁵,Choueiri Toni K.¹,Ross Robert¹,Schutz Fabio A.¹,Park Rachel S.¹,O'Brien Robert J.¹,Hirsch Michelle S.⁶,Barletta Justine A.⁶,Berman David M.⁷,Lis Rosina⁸,Loda Massimo⁸,Stack Edward C.⁸,Garraway Levi A.¹,Riester Markus³,Michor Franziska³,Kantoff Philip W.¹,Rosenberg Jonathan E.¹⁹

Affiliation:

1. Dana‐Farber Cancer Institute Boston Massachusetts

2. University of Rochester Rochester New York

3. Biostatistics and Computational Biology Harvard Medical School Boston Massachusetts

4. Htal De Mar Research Institute‐IMIM Barcelona Spain

5. Department of Clinical Therapeutics University of Athens Medical School Athens Greece

6. Department of Pathology Brigham and Women's Hospital Harvard Medical School Boston Massachusetts

7. Department of Pathology and Molecular Medicine Queen's University Kingston Ontario Canada

8. Center for Molecular Oncologic Pathology Brigham and Women's Hospital Boston Massachusetts

9. Memorial‐Sloan Kettering Cancer Center New York New York

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.262

Reference28 articles.

1. Fibroblast Growth Factor Receptor 1 Promotes Proliferation and Survival via Activation of the Mitogen-Activated Protein Kinase Pathway in Bladder Cancer

2. Strong immunohistochemical expression of fibroblast growth factor receptor 3, superficial staining pattern of cytokeratin 20, and low proliferative activity define those papillary urothelial neoplasms of low malignant potential that do not recur

3. FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancer

4. mRNA transcript quantification in archival samples using multiplexed, color-coded probes

5. Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The roles of FGFR3 and c-MYC in urothelial bladder cancer;Discover Oncology;2024-07-20

2. Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma;New England Journal of Medicine;2023-11-23

3. FGFR3 mutation characterization identifies prognostic and immune-related gene signatures in bladder cancer;Computers in Biology and Medicine;2023-08

4. Identification of novel lncRNA prognostic biomarkers and their associated ceRNAs in bladder urothelial carcinoma;Journal of Biochemical and Molecular Toxicology;2023-07-02

5. Large, Nested Variant of Urothelial Carcinoma Is Enriched with Activating Mutations in Fibroblast Growth Factor Receptor-3 among Other Targetable Mutations;Cancers;2023-06-13